Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment

Area of Science:

• Hematology
• Oncology
• Dermatology

Background:

• Mastocytosis is a group of disorders characterized by clonal mast cell proliferation.
• The skin is the most commonly affected organ, leading to cutaneous mastocytosis.
• Systemic variants range from indolent to aggressive forms, including mast cell leukemia.

Purpose of the Study:

• To provide a comprehensive overview of mastocytosis classification.
• To describe the clinical course and management strategies for mastocytosis.
• To highlight the heterogeneity of mastocytosis, from cutaneous to systemic variants.

Main Methods:

• Classification based on World Health Organization guidelines.
• Review of clinical manifestations and disease progression.
• Discussion of treatment goals for different mastocytosis subtypes.

Main Results:

• Cutaneous mastocytosis includes mastocytoma, maculopapular, and diffuse types.
• Systemic mastocytosis encompasses indolent, aggressive, and rare forms like mast cell leukemia.
• Disease course varies, with potential resolution in children and persistence in adults.

Conclusions:

• Mastocytosis is a heterogeneous disease with diverse clinical presentations.
• Effective management requires addressing mediator-release symptoms and mast cell burden.
• Understanding the classification is crucial for appropriate patient care.